At this time, posts about Antrogen are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 10,000 shares today. Antrogen is known as a developer and seller of stem cell therapeutics.

As of 11:30 AM on the 8th, Antrogen's stock price is 74,000 KRW, down 2.89% from the previous day, with a trading volume of 236,124 shares, which is about 20.36% of the 5-day average trading volume.

In addition to Antrogen, posts by investors are also surging for Bridge Biotherapeutics (288330), Shinil Electronics (002700), and Joa Pharmaceutical (034940).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing